Search results
Results from the WOW.Com Content Network
The EpiPen, manufactured by Meridian Medical Technologies, and marketed by Mylan, has dominated the market. [57] In 2007 when Mylan acquired the rights to market the product, annual sales of all epinephrine autoinjectors were about $200 million and EpiPen had around 90% of the market; in 2015 the market size was around $1.5 billion and Mylan ...
Epinephrine vial 1 mg (Adrenalin). Epinephrine is used to treat a number of conditions, including cardiac arrest, anaphylaxis, and superficial bleeding. [25] It has been used historically for bronchospasm and low blood sugar, but newer treatments for these that are selective for β 2 adrenoceptors, such as salbutamol, are preferred.
Brand names include Anapen, EpiPen, Emerade, and Auvi-Q. [citation needed] Rebiject, Rebiject II and Rebidose autoinjectors for Rebif, the drug for interferon beta-1a used to treat multiple sclerosis. An autoinjector for the Avonex version of this same medication is also on the market. [citation needed]
Pfizer Inc (NYSE: PFE) has agreed to pay $345 million to resolve claims by consumers claiming they overpaid for EpiPens due to anti-competitive and unfair practices, reports Reuters. The proposed ...
An injector pen consists of a chamber or cartridge of medication, a tip to attach a needle, and a piston or plunger to inject the dose. [4] Some pens, including most insulin pens, include dials to adjust the dose of the injection before each administration. [2]
Meridian Medical Technologies, LLC is an American company which specialized primarily in developing and manufacturing antidotes for chemical weapons.. It was founded in 1968 as Brunswick Biomedical Corporation and changed its name in November 1996 [1] when it merged with Survival Technology, Inc. [2] Survival Technology, Inc. had been the employer of Sheldon Kaplan, who had invented various ...
Intracardiac injections of drugs were generally used only to provide emergency drugs to a patient if other approaches would be ineffective; for example if drugs could not be administered intravenously due to individual circumstances.
Persons with a history of severe anaphylactic reaction may carry an injectable emergency dose of epinephrine (such as an EpiPen). Oral steroids may also be helpful. Allergy immunotherapy has been reported to improve or cure OAS in some patients. Immunotherapy with extracts containing birch pollen may benefit those with apple or hazelnut related ...